Rheumatoid Factor Solution

Rheumatoid Factor Solution_x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_

Catalog number:	S2010001
Lot number:	Batch dependent
Expiration date:	Batch depdendent
Concentration:	‚â•1500 IU/mL
Package Size:	1 mL
Appearance:	Slightly turbid
Species:	Human
Matrix:	Defibrinated human plasma
Storage:	-20°C. Avoid repeated freeze-thaw.
Other names:	RF, rheumatoid arthritis factor, rheumatoid arthritis antibody
Keywords:	Rheumatoid Factor, RF, rheumatoid arthritis factor, rheumatoid arthritis antibody

_x000D_

All Interference Products Brochure_x000D_

_x000D_ _x000D_ _x000D_ References_x000D_ _x000D_

_x000D_
• Hollander, J. L. (1968). Rheumatoid Arthritis, Rheumatoid Factor, and Gamma G Globulin Fragments. Annals of Internal Medicine, 68(5), 1195.
_x000D_
• Pappas, D. A., and Bathon, J. M. (2009). Treatment of Rheumatoid Arthritis: Tumor Necrosis Factor Inhibitors. Rheumatoid Arthritis, 337‚Äì349.
_x000D_
• Shingu, M., Ezaki, I., and Nobunaga, M. (1988). Complement-activating properties of immune complexes are suppressed by IgM rheumatoid factor and enhanced by IgG rheumatoid factor. Rheumatology International, 8(3), 95‚Äì100.
_x000D_
• Vaughan, J. H. (1993). Pathogenetic concepts and origins of rheumatoid factor in rheumatoid arthritis. Arthritis and Rheumatism, 36(1), 1‚Äì6.
_x000D_
• Xing Q, Fu L, Yu Z, Zhou X. Efficacy and Safety of Integrated Traditional Chinese Medicine and Western Medicine on the Treatment of Rheumatoid Arthritis: A Meta-Analysis. Evid Based Complement Alternat Med. 2020 Apr 2;2020:4348709.
_x000D_
• Raine C, Austin K, Giles I. Mechanisms determining the amelioration of rheumatoid arthritis in pregnancy: A systematic review. Semin Arthritis Rheum. 2020 Mar 19. pii: S0049-0172(20)30079-2.
_x000D_
• Toussirot E. The Interrelations between Biological and Targeted Synthetic Agents Used in Inflammatory Joint Diseases, and Obesity or Body Composition. Metabolites. 2020 Mar 13;10(3). pii: E107.
_x000D_
• Ishikawa Y, Terao C. The Impact of Cigarette Smoking on Risk of Rheumatoid Arthritis: A Narrative Review. Cells. 2020 Feb 19;9(2). pii: E475.
_x000D_
• Lin YJ, Anzaghe M, Sch√ºlke S. Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis. Cells. 2020 Apr 3;9(4). pii: E880.
_x000D_
• Capone A, Volpe E. Transcriptional Regulators of T Helper 17 Cell Differentiation in Health and Autoimmune Diseases. Front Immunol. 2020 Mar 12;11:348.
_x000D_

_x000D_ Related Products to Rheumatoid Factor Solution_x000D_ _x000D_ _x000D_ https://moleculardepot.com/product/rheumatoid-factor-interference-kit/_x000D_ _x000D_ https://moleculardepot.com/product/rheumatoid-factor-diluent/_x000D_ _x000D_ https://moleculardepot.com/product/rheumatoid-factor-interference-blocker-rf/_x000D_ _x000D_ https://moleculardepot.com/product/interference-test-kit-for-assay-validation/_x000D_ _x000D_ https://moleculardepot.com/product/triglyceride-mix/_x000D_ _x000D_  

Catalog #: S2010001 (1 mL)

0.15

2

0.5